3-(2-(heteroaryl)-pyridin-4-yl)-5-(trifluoromethyl)-1,2,4-oxadiazole derivatives as hdac6 inhibitors

HRP20260656T1Active Publication Date: 2026-07-03ORYZON GENOMICS SA
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
HR · HR
Patent Type
Patents
Current Assignee / Owner
ORYZON GENOMICS SA
Filing Date
2020-06-05
Publication Date
2026-07-03
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.